Preliminary noteThe competitive NMDA antagonist CGP40.116 enhances L-DOPA response in MPTP-treated marmosets
References (14)
- et al.
Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study
Neurosci.
(1992) Primate models of dyskinesias: The experimental approach to the study of basal ganglia related involuntary movement disorders
Neurosci.
(1987)- et al.
Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey
Neuropharmacol.
(1989) - et al.
Excitatory amino acids and the basal ganglia: implications for therapy of Parkinson's disease
Trends Neurosci.
(1989) - et al.
Are N-methyl-D-aspartate (NMDA) and phencyclidine (PCP) receptors always functionally coupled to each other?
Neurochem. Int.
(1990) - et al.
Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
Science
(1990) - et al.
Alleviation of Parkinsonism by Antagonism of Excitatory Amino Acid Transmission in the Medial Segment of the Globus Pallidus in Rat and Primate
Movement Disorders
(1991)
There are more references available in the full text version of this article.
Cited by (41)
Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease
2000, Experimental NeurologyReversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: Potential mechanisms of action
1997, Neuroscience and Biobehavioral ReviewsStimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease
1997, Neuroscience and Biobehavioral ReviewsBehavioural pharmacology of glutamate receptors in the basal ganglia
1997, Neuroscience and Biobehavioral ReviewsModulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease
1997, Neuroscience and Biobehavioral Reviews
Copyright © 1984 Published by Elsevier Ltd.